Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07028658

Effectiveness of Speech Therapy for Lip-reading in Patients With Hearing Aids: SCED Study

This study aims to investigate whether lip reading rehabilitation improves viseme recognition in individuals with hearing impairments who use hearing aids.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hearing Loss, Bilateral or Unilateral Ear Diseases Hearing Disorders Hearing Loss Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient aged 18 or older
  • Affiliated with a social security system
  • Moderate to severe bilateral post-lingual hearing loss, fitted with hearing aids for more than 6 months
  • Wearing hearing aids for a minimum of 8 hours/day on average over the past month
  • Intelligibility in quiet > 80% correct responses at 60 dB (Lafon cochlear list)
  • Difficulty in noisy environments rated > 6 on a 0-10 EVA scale
  • French language comprehension level of at least B1 CEFR (Common European Framework of Reference for Languages)
  • Willing to participate in speech therapy rehabilitation at a rate of 2 sessions per week

Exclusion criteria

  • Patient who has already undergone speech therapy rehabilitation as part of their hearing loss treatment
  • Diagnosis of neurodegenerative disease or history of brain injury (traumatic brain injury, stroke, tumor, meningitis, etc.)
  • Uncorrected vision or visual impairment affecting lip reading (e.g. AMD, glaucoma, unoperated cataract, etc.)
  • Presence of severe tinnitus (score > 56) on the Tinnitus Handicap Inventory (THI) questionnaire
  • Significant cognitive impairment (CODEX C or D) or Montreal Cognitive Assessment (MOCA) score < 23

Treatment and study plan

Speechreading training

Other

The patient will undergo 16 lip reading training sessions. By developing functional lip reading skills, they will be able to fill in the gaps in auditory information they miss, especially in loud or noisy settings

Primary outcomes

  1. Repetition score, in words (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality

    Time frame: 26 sessions (4,5 months)

  2. Repetition score, in visemes (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality

    Time frame: 26 sessions (4,5 months)

Secondary outcomes

  1. Repetition score of 10 non-words on recorded support with a Signal-to-Noise Ratio of 10

    Time frame: 26 sessions (4,5 months)

  2. Repetition score of sentences on video support in audiovisual modality

    Time frame: 26 sessions (4,5 months)

  3. Identification score of two sequences of musical notes

    Time frame: 26 sessions (4,5 months)

  4. Impact of speech therapy rehabilitation on quality of life

    Time frame: 26 sessions (4,5 months)

    AVS from 0 to 10

Sponsors and collaborators

Lead sponsor

Institut Pasteur

Industry

Collaborators

  • IHU reConnect

Registry information

Official study title

Efficacité de la rééducation Orthophonique de la Lecture Labiale Des Patients appareillés Auditifs : étude SCED

Acronym: SCEDuLL

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 19, 2025
Registry last updated
Apr 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.